Olive
The business, the turning points, and the decisions behind them.
01 / WHAT IT BUILT
What the company did
Olive automated healthcare administrative work, including prior authorization and revenue-cycle workflows.
02 / Olive FAILURE REASONS
Failure reasons
CEO Sean Lane acknowledged in 2022 that rapid growth and insufficient focus overloaded product and engineering teams and slowed important initiatives. Amid difficult market conditions, the company reduced staff and sold business lines. Selling its remaining core units in 2023 led to winding down the rest.
03 / EVENT HISTORY
Events in the structured record
- Large layoffs and strategy correction
In July the company cut 450 jobs and acknowledged strategic execution problems.
- Core assets sold and wind-down announced
On 31 October Olive announced sales to Waystar and Humata Health and the winding down of remaining operations.
04 / CONTEMPORARY REBUILD ASSESSMENT
Difficulty of rebuilding this project today
Material for this section is being gathered and checked. It will appear here once ready.
Overall assessment: Not completed
05 / CAUSAL CHAIN
How the factors connect
- 01
Rapid growth and lack of focus strained execution, according to CEO
- 02
Headcount and business lines reduced
- 03
Remaining core units sold
- 04
Remaining business wound down